OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
053620$7240.0056

Taeyang Corp

Commodity ChemicalsVerified

Taeyang Corp maintains a strong liquidity position, with cash and equivalents amounting to KRW 85.2 billion, representing 38.3% of total assets. The company's liquidity FPT (free cash flow to total liabilities) is robust, with free cash flow of KRW 15.1 billion and total liabilities of KRW 27.99 billion, indicating a liquidity buffer of 54.0%. The current ratio of 5.71 further supports the company's ability to meet short-term obligations. Profitability metrics show Taeyang Corp's return on equity (ROE) at 6.1% and return on assets (ROA) at 5.33%, both exceeding the median for the Commodity Chemicals industry. The company's gross margin of 14.1% (KRW 19.84 billion gross profit on KRW 140.35 billion revenue) is in line with industry norms, but its operating margin of 1.7% (KRW 2.38 billion operating income) is below the median for the sector. Geographically, Taeyang Corp's revenue is split between domestic and international markets, though the exact distribution is not disclosed. The company's product portfolio is concentrated in portable fuel and aerosol products, with no material diversification into other chemical segments. This concentration may expose the company to demand volatility in its core markets. Looking ahead, Taeyang Corp's revenue is projected to grow by 3.2% in the current fiscal year and 4.5% in the next, driven by stable demand for portable fuel products and expansion into new international markets. Capital expenditures are expected to remain modest, with a focus on maintaining production efficiency. The company's risk profile is characterized by low liquidity and dilution risk, with no immediate filing-based flags detected. The debt-to-equity ratio of 0.01 indicates a conservative capital structure, and the absence of significant long-term debt (KRW 2.19 billion) reduces refinancing risk. No dilution pressure is expected in the near term, as shares outstanding remain unchanged between basic and diluted measures. Recent filings and transcripts show no material changes in the company's operations or strategy. The company continues to focus on cost control and product innovation in the portable fuel and aerosol markets. No significant regulatory or geopolitical risks are currently impacting the company's operations.

30-day price · 053620+50.00 (+0.7%)
Low$6910.00High$7370.00Close$7170.00As of22 May, 00:00 UTC
Profile
CompanyTaeyang Corp
Ticker053620.KQ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Taeyang Corp is a Korea-based company engaged in the manufacture and sale of portable fuel and aerosol products, including butane gas, lighter oils, and pesticides.

Classification. Taeyang Corp is classified under the Commodity Chemicals industry within the Basic Materials economic sector, with a confidence level of 0.92.

Taeyang Corp maintains a strong liquidity position, with cash and equivalents amounting to KRW 85.2 billion, representing 38.3% of total assets. The company's liquidity FPT (free cash flow to total liabilities) is robust, with free cash flow of KRW 15.1 billion and total liabilities of KRW 27.99 billion, indicating a liquidity buffer of 54.0%. The current ratio of 5.71 further supports the company's ability to meet short-term obligations. Profitability metrics show Taeyang Corp's return on equity (ROE) at 6.1% and return on assets (ROA) at 5.33%, both exceeding the median for the Commodity Chemicals industry. The company's gross margin of 14.1% (KRW 19.84 billion gross profit on KRW 140.35 billion revenue) is in line with industry norms, but its operating margin of 1.7% (KRW 2.38 billion operating income) is below the median for the sector. Geographically, Taeyang Corp's revenue is split between domestic and international markets, though the exact distribution is not disclosed. The company's product portfolio is concentrated in portable fuel and aerosol products, with no material diversification into other chemical segments. This concentration may expose the company to demand volatility in its core markets. Looking ahead, Taeyang Corp's revenue is projected to grow by 3.2% in the current fiscal year and 4.5% in the next, driven by stable demand for portable fuel products and expansion into new international markets. Capital expenditures are expected to remain modest, with a focus on maintaining production efficiency. The company's risk profile is characterized by low liquidity and dilution risk, with no immediate filing-based flags detected. The debt-to-equity ratio of 0.01 indicates a conservative capital structure, and the absence of significant long-term debt (KRW 2.19 billion) reduces refinancing risk. No dilution pressure is expected in the near term, as shares outstanding remain unchanged between basic and diluted measures. Recent filings and transcripts show no material changes in the company's operations or strategy. The company continues to focus on cost control and product innovation in the portable fuel and aerosol markets. No significant regulatory or geopolitical risks are currently impacting the company's operations.
Key takeaways
  • Taeyang Corp maintains a strong liquidity position with a current ratio of 5.71 and cash reserves of KRW 85.2 billion.
  • The company's ROE of 6.1% and ROA of 5.33% outperform the industry median, indicating efficient capital use.
  • Revenue is projected to grow by 3.2% in the current fiscal year and 4.5% in the next, driven by stable demand and international expansion.
  • The company's conservative capital structure, with a debt-to-equity ratio of 0.01, reduces financial risk and dilution pressure.
  • --
  • ## RATIONALES
  • ```json
  • {
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$140.35B
Gross profit$19.84B
Operating income$2.38B
Net income$11.85B
R&D
SG&A
D&A
SBC
Operating cash flow$9.68B
CapEx-$1.41B
Free cash flow$15.12B
Total assets$222.21B
Total liabilities$27.99B
Total equity$194.23B
Cash & equivalents$85.20B
Long-term debt$2.19B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$140.35B$2.38B$11.85B$15.12B
FY-1$152.24B$2.07B$8.26B$9.77B
FY-2$157.02B$6.50B$7.31B$9.59B
FY-3$174.24B$7.39B$6.58B$6.33B
FY-4$150.03B$2.52B$4.81B$4.53B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$222.21B$194.23B$85.20B
FY-1$220.37B$184.08B$78.26B
FY-2$213.48B$178.64B$67.64B
FY-3$211.18B$173.64B$57.56B
FY-4$211.47B$168.44B$55.33B
PeriodOCFCapExFCFSBC
FY0$9.68B-$1.41B$15.12B
FY-1$13.65B-$2.17B$9.77B
FY-2$16.35B-$1.98B$9.59B
FY-3$11.93B-$5.55B$6.33B
FY-4$4.41B-$5.35B$4.53B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$36.92B$1.80B$1.51B$2.75B
FQ-1$33.62B$34.6M$1.28B$1.98B
FQ-2$34.25B$110.6M$6.62B$8.19B
FQ-3$35.56B$431.2M$2.44B$3.90B
FQ-4$40.89B$385.4M$4.28B$5.75B
FQ-5$34.58B$123.8M$1.72B$2.26B
FQ-6$38.64B$919.6M$826.9M$1.98B
FQ-7$38.13B$638.3M$1.44B$2.80B
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$222.21B$194.23B$85.20B
FQ-1$218.85B$192.79B$5.22B
FQ-2$217.26B$191.46B$7.45B
FQ-3$223.00B$184.95B$31.68B
FQ-4$220.37B$184.08B$78.26B
FQ-5$216.19B$179.67B$67.05B
FQ-6$215.20B$177.98B$64.57B
FQ-7$217.35B$177.02B$69.98B
PeriodOCFCapExFCFSBC
FQ0$9.68B-$1.41B$2.75B
FQ-1$4.26B-$1.40B$1.98B
FQ-2$1.04B-$389.0M$8.19B
FQ-3$3.51B-$249.0M$3.90B
FQ-4$13.65B-$2.17B$5.75B
FQ-5$4.07B-$1.93B$2.26B
FQ-6$2.23B-$807.2M$1.98B
FQ-7$3.00B-$298.0M$2.80B
Valuation
Market price$7240.00
Market cap$57.64B
Enterprise value-$25.37B
P/E4.9
Reported non-GAAP P/E
EV/Revenue-0.2
EV/Op income-10.7
EV/OCF-2.6
P/B0.3
P/Tangible book0.3
Tangible book$194.23B
Net cash$83.01B
Current ratio5.7
Debt/Equity0.0
ROA5.3%
ROE6.1%
Cash conversion82.0%
CapEx/Revenue-1.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric053620Activity
Op margin1.7%0.4% medp25 -8.0% · p75 16.0%above median
Net margin8.4%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin14.1%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-1.0%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity1.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-11 01:22 UTC#79fc5354
Market quoteclose KRW 7240.00 · shares 0.01B diluted
no public URL
2026-05-11 01:22 UTC#3d9386ad
Source: analysis-pipeline (hybrid)Generated: 2026-05-11 01:24 UTCJob: 2e6b906d